Based on the efficacy of GDNF as a survival factor of dopaminergic and motor neurons, establishing neurons expressing GDNF from iPS or ES cells could be beneficial for treating neurodegenerative diseases, such as Parkinson’s disease. The gene discussed is GDNF; the disease is Parkinson disease.